Metabolic glycan labeling immobilizes dendritic cell membrane and enhances antitumor efficacy of dendritic cell vaccine.

Metabolic glycan labeling immobilizes dendritic cell membrane and enhances antitumor efficacy of dendritic cell vaccine.
复制标题

DOI:
10.1038/s41467-023-40886-7
复制
发表时间:
2023-08-19
影响因子:
16.6
通讯作者:
Wang, Hua
Wang, Hua
中科院分区:
综合性期刊1区
文献类型:
--
作者:
Han, Joonsu;Bhatta, Rimsha;Liu, Yusheng;Bo, Yang;Elosegui-Artola, Alberto;Wang, Hua

文献摘要

参考文献

被引文献

相似文献

树突状细胞 (DC) 疫苗是 FDA 首批批准的癌症免疫疗法之一,但受到细胞毒性 T 淋巴细胞 (CTL) 反应和治疗效果有限的限制。在这里,我们报告了一种简便的代谢标记方法,该方法能够对过继转移的 DC 进行有针对性的调节,以开发增强型 DC 疫苗。我们发现代谢聚糖标记可以降低 DC 的膜迁移率,从而激活 DC 并改善 DC 的抗原呈递和随后的 T 细胞启动特性。代谢聚糖标记本身可以增强DC疫苗的抗肿瘤功效。此外,通过代谢聚糖标记引入的细胞表面化学标签(例如叠氮基)还能够在体内将细胞因子缀合到过继转移的 DC 上,从而进一步增强 CTL 反应和抗肿瘤功效。我们的 DC 标记和靶向技术提供了一种提高 DC 疫苗治疗效果的策略,同时对临床生产过程的干扰最小。树突状细胞 (DC) 疫苗是 FDA 首批批准的癌症免疫疗法之一,但由于疗效有限而受到限制。在此,作者报告了一种简便的代谢聚糖标记方法,可改善 DC 疫苗的细胞毒性 T 淋巴细胞反应和抗肿瘤功效。
Dendritic cell (DC) vaccine was among the first FDA-approved cancer immunotherapies, but has been limited by the modest cytotoxic T lymphocyte (CTL) response and therapeutic efficacy. Here we report a facile metabolic labeling approach that enables targeted modulation of adoptively transferred DCs for developing enhanced DC vaccines. We show that metabolic glycan labeling can reduce the membrane mobility of DCs, which activates DCs and improves the antigen presentation and subsequent T cell priming property of DCs. Metabolic glycan labeling itself can enhance the antitumor efficacy of DC vaccines. In addition, the cell-surface chemical tags (e.g., azido groups) introduced via metabolic glycan labeling also enable in vivo conjugation of cytokines onto adoptively transferred DCs, which further enhances CTL response and antitumor efficacy. Our DC labeling and targeting technology provides a strategy to improve the therapeutic efficacy of DC vaccines, with minimal interference upon the clinical manufacturing process. Dendritic cell (DC) vaccines were among the first FDA-approved cancer immunotherapies but have been limited by the modest therapeutic efficacy. Here, authors report a facile metabolic glycan labeling approach to improving the cytotoxic T lymphocyte response and antitumor efficacy of DC vaccines.
DOI: 10.1084/jem.20021598
发表时间: 2002-12-16
影响因子: 15.3
作者:
Bonifaz, L;Bonnyay, D;Mahnke, K;Rivera, M;Nussenzweig, MC;Steinman, RM
通讯作者: Steinman, RM
DOI: 10.3389/fimmu.2017.01594
发表时间: 2017
影响因子: 7.3
作者:
Hargadon KM
通讯作者: Hargadon KM
DOI: 10.1056/nejmoa1001294
发表时间: 2010-07-29
影响因子: 158.5
作者:
Kantoff, Philip W.;Higano, Celestia S.;Young, J.
通讯作者: Young, J.
DOI: 10.1073/pnas.1610544113
发表时间: 2016-11-29
影响因子: 11.1
作者:
Hurton, Lenka V.;Singh, Harjeet;Cooper, Laurence J. N.
通讯作者: Cooper, Laurence J. N.
DOI: 10.1038/nrc.2016.97
发表时间: 2016-08-23
期刊: Nature reviews. Cancer
影响因子: --
作者:
Fesnak AD;June CH;Levine BL
通讯作者: Levine BL